PRESS RELEASE published on 05/22/2026 at 22:05, 2 months 10 days ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC Abivax reports Q1 2026 financial results and interim data from UC Study 108, showing strong clinical remission with obefazimod. Cash position at €491.6M. Updates on upcoming trials and financial highlights Financial Results Abivax Obefazimod Clinical Trials UC Study 108
BRIEF published on 05/11/2026 at 22:10, 2 months 21 days ago Abivax: Results of the 2026 Annual General Meeting Biotechnology Abivax Resolutions General Assembly Immune Response
BRIEF published on 05/11/2026 at 22:10, 2 months 21 days ago Abivax Reports Outcomes of Annual General Meeting Shareholders Abivax Ulcerative Colitis Annual Meeting Resolutions
PRESS RELEASE published on 05/11/2026 at 22:05, 2 months 21 days ago Abivax Announces Results of its May 11, 2026 Annual General Meeting Abivax announces results of its annual general meeting for 2026, including resolutions adopted and details on financial statements and compensation policy Annual General Meeting Shareholders Financial Statements Biotechnology Abivax
BRIEF published on 05/05/2026 at 08:05, 2 months 28 days ago Abivax Reacquires Royalty Certificates and Proceeds with $45M ADS Offering Abivax Financial Strategy Royalty Certificates ADS Offering Dilution Impact
PRESS RELEASE published on 05/05/2026 at 08:00, 2 months 28 days ago Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares Abivax announces repurchase of royalty certificates and pricing of $45M (€38.5M) offering of American Depositary Shares to strengthen balance sheet and enhance shareholder value Abivax Repurchase American Depositary Shares Royalty Certificates $45M Offering
BRIEF published on 04/27/2026 at 18:05, 3 months 4 days ago ABIVAX: Composition of share capital and voting rights Euronext Paris Share Capital Voting Rights Abivax Number Of Shares
BRIEF published on 04/22/2026 at 22:10, 3 months 9 days ago Abivax unveils key data on obefazimod at Digestive Disease Week Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week
BRIEF published on 04/22/2026 at 22:10, 3 months 9 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE published on 04/22/2026 at 22:05, 3 months 9 days ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease
Published on 08/01/2026 at 01:20, 1 day 11 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 11 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 11 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 13 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 4 hours 7 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 19 hours 47 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 16 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 17 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 15 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 17 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 17 hours ago Covivio Hotels - 2026 Half-year financial report